retatrutide clinical trials First phase 3 data for are here folks. This drug is a barn burner. This was only 68 weeks and was geared towards osteoarthritis of the knee. Massive pain improvements and retatrutide peptide | peptidesskin
Description
Discontinuation typically results in weight regain, with patients recovering approximately two-thirds of lost weight within 12 months after stopping treatment
And if I think like, oh, this is like cardiovascular disease, then then we need to be focusing there, not waiting until things change
In turn, nausea is the main adverse event associated with GLP-1RAs class
For many women, traditional diets and exercise simply arent enough
A: Clinical trials show weight loss ranging from 5% to over 20% of body weight, depending on the medication and individual factors
